UMass Amherst chemists have developed a three-color fluorescent method to visualize different mRNA molecules inside living ...

Find out how different vaccines for the coronavirus cause your body to create antibodies that fight the virus.

Two of the vaccines we have for COVID-19 have the distinction of being the first mRNA vaccines to see widespread use in humans. But how do they work, and how are they different from all the ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that ...

The Stanford summary backs up the "rare" label with specific numbers: about one myocarditis case per 140,000 people after a ...

Sean Ryder, professor at UMass Chan Medical School, has written a book to delve the mysteries of ribonucleic acid as a tool to fight diseases. Messenger ribonucleic acid, or mRNA, is in the public ...

A preliminary study found that people receiving immunotherapy for lung cancer or melanoma lived longer if they had received ...

MIT and Broad Institute researchers have developed an mRNA approach that temporarily programs liver cells to produce ...

New data highlight liver-encoded delivery of immune modulators as a strategy to mitigate age-related immune dysfunction.

From GLP-1 weight-loss drugs and mRNA cancer vaccines to longevity science and regenerative medicine, 2025 marked a decisive ...

No matter where cancer cells grow in the human body, they are a threat to our health and our lives. But instead of treating them with chemotherapy or radiation - which have undesirable side effects - ...

Moderna (MRNA) is back in the spotlight after securing up to $54.3 million from CEPI to help fund a Phase 3 trial of its H5 bird flu vaccine candidate, mRNA-1018. See our latest analysis for Moderna.